Erratum: Crizotinib Treatment for Lorlatinib-resistant MET-amplified EML4-ALK-fusion Positive Advanced Lung Adenocarcinoma: A Case Report

Saved in:
Bibliographic Details
Main Author: Editorial Office of Chinese Journal of Lung Cancer
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2025-03-01
Series:Chinese Journal of Lung Cancer
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2025.103.01
Tags: Add Tag
No Tags, Be the first to tag this record!